(DYAX:Consolidated Issue listed on NASDAQ Global Market)
Henry E. Blair
Co-Founder, Chairman of The Board and Member of Strategy & Science Committee, Dyax Corp.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 3 different organizations across 7 different industries.|
See Board Relationships
Mr. Henry E. Blair was a Co-founder of Genzyme Corporation. Mr. Blair is a Co-Founder of Dyax Corporation and served as its Chief Executive Officer from 1997 to January 01, 2009 and the President from August 1995 to January 01, 2009. He co-founded Biocode, Inc., and GelTex Pharmaceuticals, Inc. Mr. Blair has been the Chairman of Dyax Corporation since August 1995 and as its Director since 1989. Mr. Blair served as a Director of Esperion Therapeutics, Inc.
55 Network DrivePhone: 617-225-2500
Burlington, Massachusetts 01803
Board Members Memberships*
Co-Founder, Chairman of The Board and Member of Strategy & Science Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Jon P. Stonehouse||Chief Executive Officer, President and Executive Director|
BioCryst Pharmaceuticals, Inc.
|Sijmen de Vries M.D., MBA||Chief Executive Officer and Member of Management Board|
Pharming Group NV
|John W. Varian||Chief Executive Officer, President and Director|
|Simon E. Moroney Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Jan G. J. van de Winkel Ph.D.||Co-Founder, Chief Executive Officer and President|
|kr10.7M||Compensation as of Fiscal Year 2013.|